drug protocol number

YS/003

drug sponsor

The Australian and New Zealand Intensive Care Research Centre, Monash University, Australia

drug study

Dexmedetomidine

drug trial site

King Saud Medical City (Riyadh)

drug status

Ongoing

drug phase